A case series evaluation of standardized exercise dosage using a cycle ergometer on body weight and patient-reported outcome measures among overweight female patients with knee osteoarthritis.
Tomoki Oka, Yoshihide Tokuda, Kotaro Tamari
A stepwise cycle-ergometer programme up to 10 KKW was safe in four overweight women with knee OA.
One of three lost significant weight in the higher-dose phase; knee function scores improved in all. This is a case series, not proof the exercise works.
Key findings
1A 74-year-old woman with knee OA tolerated a progressive cycle-ergometer programme up to 10 KKW without adverse events. At 11 KKW she had a near-fall from knee buckling, and the dose was reduced to 10 KKW, where it was maintained without further incident.
2In the three-participant phase, only Case I (SMI 5.6 kg/m²) showed a significant body-weight reduction in the higher-dose phase, a 1.3 kg drop with a very large effect size. Cases II and III showed no significant change in any phase.
3Knee function scores (JKOM, a 25-item questionnaire with a total score from 0 to 100, higher meaning worse) improved in all three participants, with the largest gains in the higher-dose phase.
Still to come
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Four participants in total (one in the feasibility phase, three in the main phase). This is not evidence that the intervention works; it is a description of what happened to four individuals. No washout period between the four 5-week phases, so changes in later phases may reflect carryover from earlier ones rather than the specific intervention in that phase. Body-weight data for Phase A were missing in two of the three main-phase participants, which weakened the baseline comparison. Each phase lasted only 5 weeks, which the authors note may be too short to see sustained effects on weight or function. The KKW dosing guidelines were derived from Western populations and may not transfer directly to Asian patients, who tend to have higher body-fat percentages at the same BMI. Caloric intake was estimated by a wearable device rather than measured directly, so compensatory eating cannot be ruled out.
Declared interests
The authors declare no conflicts of interest.
The easy way to misread this
Do not read the 1.3 kg weight loss in one of three participants as evidence that cycle-ergometer exercise reduces body weight in knee OA. This is a case series with no control group, no washout between phases, and two of three participants showed no significant change. The single positive result may reflect that participant's higher muscle mass rather than the exercise itself.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →